// App-Quantinova.ai

2615 : Cumulative Incidence, Survival and Predictors of Pulmonary Arterial Hypertension in Disease Subsets of Systemic Sclerosis: PAH Is Not Increased in Limited vs Diffuse Patients by Adjusted Competing Risk Analysis

Researchers

Presenter

  • Tatiana Nevskaya

Principal Investigators

  • Yuxuan Jiang

  • Mianbo Wang

Medical Centers

  • University of Western Ontario, London, ON, Canada

  • Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.

  • Western Univeristy, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Autoimmune (AI)

Disease

  • Pulmonary arterial hypertension

  • Scleroderma

  • Hypertension

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved